Food Marketing Reaches a New Low: Buyers Beware

On April 15, 2017, Emma Morano passed away peacefully in Verbania, Italy at the age of 117 years, 137 days, and 16 hours! She was the oldest person in the world, according to her obituary. What explains her longevity?

She lived very quietly in a church-owned apartment near beautiful Lake Maggiore. Was the lake's mild climate a factor, or perhaps the three raw eggs she ate every day for nearly a century? As always with long life, the role of diet emerges. Was it the three eggs each day or the lack of processed foods and sodas, or any number of other possible factors? How to live a long, healthy life has become an obsession in modern times as it seems we become less and less healthy.

New Studies Examine the Use of Liquid Biopsies and the Possible Causes of Myeloma

Two newly published studies that received funding from the IMF Black Swan Research Initiative® show how myeloma might be diagnosed and monitored in the future, and, perhaps, the genetic factors that might cause the disease. In his blog this week, IMF Chairman Dr. Brian Durie translates the studies’ implications and offers important caveats for patients to keep in mind. 

 

The Secrets to a Long, Healthy Life Remain Elusive: Updates from Around the World

The Tsimane tribe lives in the Amazon lowlands of Bolivia. For some reason, according to a new study published in The Lancet, they do not get heart disease! The study, notes the New York Times, paired anthropologists with cardiologists to investigate.

PET/CT Scanning Comes of Age: New IMWG Guidelines Published

New IMWG guidelines for PET/CT scanning have been published inThe Lancet Oncology. In his blog this week, IMF Chairman Dr. Brian Durie congratulates Dr. Michele Cavo and his team for their report on this extremely accurate imaging technique, used to establish a diagnosis and to monitor throughout the course of the disease. “The new IMWG guidelines provide a comprehensive review of the current role and optimal uses of FDG PET/ CT scanning,” he writes.

US FDA Lifts Partial Clinical Hold on Karyopharm’s Selinexor Clinical Trials

When there is so much that is negative in the news, it is great to be able to report today that myeloma clinical trials with selinexor (KPT-330) can again move forward.

Pages